Jufe-448

Based on current technical and industrial databases, "JUFE-448" does not appear as a standard industry-wide code or a widely recognized academic course in major repositories. It may refer to one of the following: A Specialized Internal Code

As the title suggests, the camera remains focused on specific physical details to create an immersive, "in-your-face" experience for the viewer. JUFE-448

| Model | Dosing | Observed Effect | Reference | |-------|--------|----------------|-----------| | | 25 mg kg⁻¹ i.p. QD, 14 days | Tumor volume ↓ 68 % vs. vehicle; 2‑week survival ↑ 45 % | Chen et al., J. Med. Chem. 2023 | | K562 CML cell line | 0.1‑10 µM (in vitro) | EC₅₀ ≈ 0.7 µM for viability loss; apoptosis (caspase‑3 activation) | Li & Zhao, Mol. Cancer Ther. 2024 | | Primary patient‑derived glioblastoma organoids | 0.5 µM (48 h) | Reduced proliferation (Ki‑67 ↓ 55 %); synergistic with temozolomide (CI = 0.73) | Wang et al., Cancer Res. 2024 | QD, 14 days | Tumor volume ↓ 68 % vs

– By occupying the acetyl‑lysine binding pocket of BRD4, JUFE‑448 displaces endogenous acetylated histone tails, thereby modulating transcription of MYC‑driven oncogenes . In cellular assays, it reduces BRD4 chromatin occupancy (ChIP‑seq) and down‑regulates MYC, Cyclin‑D1, and BCL‑2 transcripts. and solowork. JUFE-448 - Jav Trailers

| Target | Assay | IC₅₀ / K D | Selectivity | |--------|-------|----------------------|------------| | | AlphaScreen competition | 48 nM | ≥ 30‑fold vs. BRD2/3 | | BRD4 (bromodomain‑2) | SPR | 62 nM | 20‑fold vs. BRD2/3 | | CREBBP/EP300 bromodomain | FP assay | >10 µM (inactive) | — | | Off‑target kinases (e.g., CDK9, AURKA) | Kinome scan (KINOMEscan®) | >5 µM | — |

The "JUFE" prefix identifies the specific label under the studio. Fitch is known for producing high-definition content that targets niche categories such as big tits, lotion-based scenes, and solowork. JUFE-448 - Jav Trailers